Amerena John, Chen Shih-Ann, Sriratanasathavorn Charn, Cho Jeong-Gwan, Dejia Huang, Omar Razali, Fat Tse Hung, King Anthony
Geelong Cardiology Research Centre Deakin University, VIC, Australia.
Clin Med Insights Cardiol. 2011 Jan 17;5:1-6. doi: 10.4137/CMC.S6289.
The literature suggests that the prevalence of atrial fibrillation (AF) may be lower in Asian countries than in Western countries. Nevertheless, AF remains a significant public health problem in the region. The burden of AF, the experiences of previous trials and the lack of data on AF and its management in Asia Pacific highlight the need for a comprehensive prospective study of AF management.
The REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation Asia Pacific (RecordAF-AP) is a prospective, observational survey of the management of recently diagnosed AF patients with 1-year follow-up in 8 countries across Asia Pacific. Eligible patients presenting with AF, treated or not, will be included in the registry and data will be recorded prospectively during follow-up visits at 6 and 12 months.
RecordAF-AP will recruit more than 3000 patients. Study recruitment commenced in April 2009 and the final results anticipated at the end of 2011.
RecordAF-AP will assess the real-life management of AF patients in Asia Pacific, including a comparison of clinical outcomes in rhythm versus rate control strategies, providing much needed insight into the costs, treatment choices and clinical outcomes of AF patients in this region.
文献表明,亚洲国家心房颤动(AF)的患病率可能低于西方国家。然而,AF在该地区仍然是一个重大的公共卫生问题。AF的负担、既往试验的经验以及亚太地区缺乏AF及其管理的数据,凸显了对AF管理进行全面前瞻性研究的必要性。
亚太地区心房颤动控制评估心律失常登记研究(RecordAF-AP)是一项对最近诊断为AF的患者进行管理的前瞻性观察性调查,在亚太地区的8个国家进行为期1年的随访。符合条件的AF患者,无论是否接受治疗,都将被纳入登记研究,数据将在6个月和12个月的随访期间前瞻性记录。
RecordAF-AP将招募超过3000名患者。研究招募于2009年4月开始,最终结果预计在2011年底得出。
RecordAF-AP将评估亚太地区AF患者的实际管理情况,包括节律控制与心率控制策略的临床结果比较,为该地区AF患者的成本、治疗选择和临床结果提供急需的见解。